Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

multicentric Castleman disease News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

HHV8-associated multicentric Castleman disease with Kaposi sarcoma in an immunocompetent patient: a case report and review of the literature.

A recent study highlights the use of contrast-enhanced ultrasound for diagnosing parotid gland Castleman disease in pediatric patients. This research could improve diagnostic accuracy and patient outcomes in rare cases of this condition.

A recent study analyzed the morbidity burden and healthcare costs associated with idiopathic multicentric Castleman disease (iMCD). The retrospective cohort analysis provides valuable insights into the economic impact of this rare disease.

A recent study highlights that pediatric idiopathic multicentric Castleman disease often presents with severe symptoms but shows responsiveness to treatment with siltuximab. This finding underscores the potential for effective management of this rare condition in children.

Recent research highlights the diagnostic challenges associated with Castleman disease, emphasizing the need for improved clinical and pathologic understanding. This study aims to enhance diagnostic accuracy and patient outcomes for this rare condition.

A recent study published in PubMed examines the clinical characteristics and surgical outcomes of retroperitoneal unicentric Castleman disease. This single-center retrospective analysis provides valuable insights into patient management and treatment efficacy.

Recent research highlights new management strategies for Castleman disease, aiming to improve patient outcomes. These findings could influence future treatment protocols and clinical practices.

A Canadian center has applied modern classification methods to improve the understanding of Castleman disease. This research aims to enhance diagnostic accuracy and treatment approaches for this rare condition.

A new study outlines the development and validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS). This international mixed methods study aims to enhance understanding of symptom burden in patients with idiopathic multicentric Castleman disease.

A recent study explores HIV-negative KSHV/HHV8-associated multicentric Castleman disease, highlighting its concurrent occurrence with Kaposi sarcoma and POEMS-like manifestations. This research adds to the understanding of complex interactions in rare diseases.

A recent study highlights increased mucocutaneous FDG activity in paraneoplastic pemphigus linked to follicular dendritic cell sarcoma, which has transformed from Castleman disease. This research may provide insights into the complex interactions between these rare conditions.

A study highlights the significance of serum interleukin-6 (IL-6) monitoring in patients with idiopathic multicentric Castleman disease undergoing non-anti-IL-6 therapy. This research underscores the potential for IL-6 levels to inform treatment decisions and patient management.

A recent study highlights a case of idiopathic multicentric Castleman disease manifesting as recurrent acute-onset demyelinating neuropathy. This research contributes to the understanding of the disease's neurological presentations.

A recent case report highlights unilateral renal Castleman disease presenting with acute abdominal pain, contributing to the understanding of this rare condition. The literature review included in the report provides insights into clinical manifestations and management strategies.

A case report highlights retroperitoneal Castleman disease presenting as a pancreatic neoplasm, contributing to the understanding of this rare condition. The literature review provides insights into diagnosis and management strategies.

A study analyzing 700 patients reveals new insights into the full spectrum of Castleman diseases. This research enhances understanding of the disease's clinical manifestations and may inform future treatment strategies.

A case report details the angiomatous subtype of penile Kaposi sarcoma occurring alongside HIV-negative multicentric Castleman disease. This study contributes to the understanding of the complex interplay between these rare conditions.

A recent study published in PubMed explores interfollicular plasmacytosis and hyperplastic germinal centers in idiopathic multicentric Castleman disease and idiopathic plasmacytic lymphadenopathy subtype. This research may provide insights into the underlying mechanisms of these rare conditions.

A recent publication explores the histopathological grading of idiopathic multicentric Castleman disease, providing insights from a pathologist's perspective. This research aims to enhance understanding of the disease's complexities and improve diagnostic accuracy.

A case study reports successful treatment of severe polyneuropathy in a patient with HIV-negative human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin. This finding may inform future therapeutic strategies for similar cases.

Not rare diseases news,news about your rare disease.